Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder

Psychiatry Research

Volumn 178, Issue 1, 2010, Pages 112-115

  Jazayeri, Shima ^a   Keshavarz, Seyed A ^a   Tehrani Doost, Mehdi ^b   Djalali, Mahmood ^a   Hosseini, Mostafa ^a   Amini, Homayoun ^b   Chamari, Maryam ^a   Djazayery, Abolghassem ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cortisol; Cytokine; Depression; Fluoxetine; HPA axis; Omega 3 fatty acid

Indexed keywords

FLUOXETINE; HYDROCORTISONE; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG WITHDRAWAL; ENDOCRINE FUNCTION; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS PITUITARY ADRENAL AXIS; MAJOR DEPRESSION; MALE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; STEATORRHEA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 79958766746     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.04.013     Document Type: Article

References (26)

1. Das, U.N., 2007. Is depression a low-grade systemic inflammatory condition? [3] American Journal of Clinical Nutrition 85, 1665-1666.
2. Delarue, J., Matzinger, O., Binnert, C., Schneiter, P., Chiolero, R., Tappy, L., 2003. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes and Metabolism 29, 289-295.
3. Dinan, T., Siggins, L., Scully, P., O'Brien, S., Ross, P., Stanton, C., 2009. Investigating the inflammatory phenotype of major depression: focus on cytokines. Journal of Psychiatric Research 43, 471-476.
4. Eller, T., Vasar, V., Shlik, J., Maron, E., 2008. Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, 445-450.
5. Freeman, M.P., Hibbeln, J.R., Wisner, K.L., Davis, J.M., Mischoulon, D., Peet, M., Keck Jr., P.E., Marangell, L.B., Richardson, A.J., Lake, J., Stoll, A.L., 2006. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry 67, 1954-1967.
6. Himmerich, H., Binder, E.B., Kunzel, H.E., Schuld, A., Lucae, S., Uhr, M., Pollmacher, T., Holsboer, F., Ising, M., 2006. Successful antidepressant therapy restores the disturbed interplay between TNF-α system and HPA axis. Biological Psychiatry 60, 882-888.
7. Himmerich, H., Zimmermann, P., Ising, M., Kloiber, S., Lucae, S., Kunzel, H.E., Binder, E.B., Holsboer, F., Uhr, M., 2007. Changes in the hypothalamic-pituitaryadrenal axis and leptin levels during antidepressant treatment. Neuropsychobiology 55, 28-35.
8. Holsboer, F., Ising, M., 2008. CentralCRHsystemin depressionand anxiety-evidence from clinical studies with CRH1 receptor antagonists. European Journal of Pharmacology 583, 350-357.
9. Jazayeri, S., Tehrani-Doost, M., Keshavarz, S.A., Hosseini, M., Djazayery, A., Amini, H., Jalali, M., Peet, M., 2008. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Australian and New Zealand Journal of Psychiatry 42, 192-198.
10. Kauffman, R.P., Castracane, V.D., White, D.L., Baldock, S.D., Owens, R., 2005. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age. Gynecological Endocrinology 21, 129-137.
11. Kim, Y.K., Na, K.S., Shin, K.H., Jung, H.Y., Choi, S.H., Kim, J.B., 2007. Cytokine imbalance in the pathophysiology of major depressive disorder. Progress in Neuropsychopharmacoly and Biological Psychiatry 31, 1044-1053.
12. Lanfumey, L., Mongeau, R., Cohen-Salmon, C., Hamon, M., 2008. Corticosteroidserotonin interactions in the neurobiological mechanisms of stress-related disorders. Neuroscience and Biobehavioral Reviews 32, 1174-1184.
13. Leo, R., Di Lorenzo, G., Tesauro,M., Razzini, C., Forleo, G.B., Chiricolo, G., Cola, C., Zanasi, M., Troisi, A., Siracusano, A., Lauro, R., Romeo, F., 2006. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. Journal of Clinical Psychiatry 67, 1760-1766.
14. Leonard, B.E., 2005. The HPA and immune axes in stress: the involvement of the serotonergic system. European Psychiatry 20 (Suppl 3), S302-306.
15. Leonard, B.E., 2007. Psychopathology of depression. Drugs Today (Barc) 43, 705-716.
16. Lin, P.Y., Su, K.P., 2007. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. Journal of Clinical Psychiatry 68, 1056-1061.
17. Maes, M., 2008. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinology Letters 29, 287-291.
18. Marques-Deak, A.H.,Neto, F.L., Dominguez,W.V., Solis, A.C., Kurcgant, D., Sato, F., Ross, J.M., Prado, E.B., 2007. Cytokine profiles in women with different subtypes of major depressive disorder. Journal of Psychiatry Research 41, 152-159.
19. Michaeli, B., Berger, M.M., Revelly, J.P., Tappy, L., Chiolero, R., 2007. Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. Clinical Nutrition 26, 70-77.
20. Miller, D.B., O'Callaghan, J.P., 2005. Depression, cytokines, and glial function. Metabolism 54, 33-38.
21. Nikisch, G., Mathe, A.A., Czernik, A., Thiele, J., Bohner, J., Eap, C.B., Agren, H., Baumann, P., 2005. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology (Berl) 181, 751-760.
22. Pace, T.W., Hu, F., Miller, A.H., 2007. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behaviour and Immunity 21, 9-19.
23. Schule, C., Baghai, T.C., Eser, D., Schwarz, M., Bondy, B., Rupprecht, R., 2009. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients. Journal of Psychiatric Research 43, 538-545.
24. Sijben, J.W.C., Calder, P.C., 2007. Differential immunomodulationwith long-chain n-3 PUFA in health and chronic disease. Proceedings of the Nutrition Society 66, 237-259.
25. Song, C., Li, X., Kang, Z., Kadotomi, Y., 2007. Omega-3 fatty acid ethyleicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion. Neuropsychopharmacology 32, 736-744.
26. Tsao, C.W., Lin, Y.S., Chen, C.C., Bai, C.H., Wu, S.R., 2006. Cytokines and serotonin transporter in patients with major depression. Progress in Neuropsychopharmacoly and Biological Psychiatry 30, 899-905.